Eagle Pharmaceuticals Announces Receipt Of Notification Of Deficiency From Nasdaq Regarding Requirement To Timely File Annual Report On Form 10-K
Eagle Pharmaceuticals Announces Receipt Of Notification Of Deficiency From Nasdaq Regarding Requirement To Timely File Annual Report On Form 10-K
Eagle Pharmicals宣布收到纳斯达克关于及时提交10-K表格年度报告的缺陷通知
Eagle Pharmaceuticals Announces Receipt Of Notification Of Deficiency From Nasdaq Regarding Requirement To Timely File Annual Report On Form 10-K
Eagle Pharmicals宣布收到纳斯达克关于及时提交10-K表格年度报告的缺陷通知
译文内容由第三方软件翻译。
以上内容仅用作资讯或教育之目的，不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。